TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension

Background: Hypoparathyroidism (HP) is characterized by insufficient levels of parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, hypercalciuria, and a reduced quality of life (QoL). PTH replacement therapy should restore physiologic levels of PTH and restore downstream physiol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Rubin, Mishaela R, Rejnmark, Lars, Schwarz, Peter E, Vokes, Tamara J, Clarke, Bart, Ahmed, Intekhab, Hofbauer, Lorenz C, Palermo, Andrea, Marcocci, Claudio, Pagotto, Uberto, Eriksen, Erik F, Mourya, Sanchita, Markova, Denka, Pihl, Susanne, Shu, Aimee D, Khan, Aliya
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Bone and Mineral Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090331/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados